Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France
暂无分享,去创建一个
M. Dougados | A. Saraux | P. Goupille | A. Ruyssen-Witrand | P. Claudepierre | A. Tournadre | C. Lukas | J. Lucas | D. Wendling | E. Desfleurs